Gene · 3785
Papers2,279
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,279
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Kv7.2 loss-of-function causes early hyperexcitability and network remodelling. | Brain | 2026 | 42249507 | PubTator, text mining | PubMed |
| Cryptic splicing in synaptic and membrane excitability genes links TDP-43 loss to neuronal dysfunction. | Sci Transl Med | 2026 | 42234776 | PubTator, text mining | PubMed |
| Navigating the complexities of dual CNV findings: a case of DEE7 caused by a de novo KCNQ2 deletion and a Co-occurring chromosome 13 duplication - a case report and literature review. | Front Pediatr | 2026 | 42221008 | PubTator, text mining | PubMed |
| KCNQ2 Channel as a Druggable Epilepsy Target: Advances in Pharmacological Modifiers. | CNS Neurol Disord Drug Targets | 2026 | 42220125 | PubTator, text mining | PubMed |
| Evidence for Potentiation of M-Type Potassium Current by Flavonoid Corylin (3-(2,2-Dimethylchromen-6-yl)-7-hydroxychromen-4-one). | Pharmaceuticals (Basel) | 2026 | 42198387 | PubTator, text mining | PubMed |
| Burst-Suppression EEG in Early Infantile Developmental and Epileptic Encephalopathies: Phenotype, Genotype, and Outcome. | Neurology | 2026 | 42190144 | PubTator, text mining | PubMed |
| Discovery of Small-Molecule Inhibitors of the KCNQ1/Kv7.1 Potassium Channel with Virtual Screening and Functional Validation in Electrophysiological Assays and KCNQ1-Knockout Neural Stem Cells. | ACS Chem Neurosci | 2026 | 42165438 | PubTator, text mining | PubMed |
| Genotype-dependent response to combined levodopa/benserazide and trihexyphenidyl in pediatric genetic dystonia. | Brain Dev | 2026 | 42119286 | PubTator, text mining | PubMed |
| Comprehensive Pathologic and Genetic Investigation of Four Young Adults with a Short QT Interval and Sudden Unexpected Death. | J Mol Diagn | 2026 | 42092729 | PubTator, text mining | PubMed |
| KCNQ2 neonatal epilepsy: Impact of prompt diagnosis and treatment, and early predictors of outcome severity. | Epilepsia Open | 2026 | 42081271 | PubTator, text mining | PubMed |
| Unperturbed dye-based imaging of spontaneous synchronized calcium activity in iPSC-derived neuronal cultures. | iScience | 2026 | 42080132 | PubTator, text mining | PubMed |
| Ion-Channel-Mediated Drug Repurposing Opportunities Validated by Single-Cell Perturbation in Colorectal Cancer. | Int J Mol Sci | 2026 | 42074061 | PubTator, text mining | PubMed |
Self-limited Neonatal Epilepsy associated with global developmental delay and high-threshold sensory profile: A novel KCNQ3 de novo variant unusually located in the voltage sensor S4 segment of the Kv7.3 channel subunit. | Seizure | 2026 | 42024975 | PubTator, text mining | PubMed |
| Potassium Channelopathies and Precision Medicine Approaches in Epilepsy: A Systematic Review of Personalized Treatment Strategies. | Curr Neuropharmacol | 2026 | 42003125 | PubTator, text mining | PubMed |
| KCNQ2 Variants in Neonatal Epilepsy: Clinical Characteristics and Neurodevelopmental Outcomes in 30 Patients. | Neurol Genet | 2026 | 41988220 | PubTator, text mining | PubMed |
| Genetic spectrum and risk factor analysis for drug-resistant of early-onset epilepsy. | Transl Pediatr | 2026 | 41982969 | PubTator, text mining | PubMed |
| Therapeutic potential of small molecules that block receptor-induced Kv7/M-current suppression in neuroprotection, seizures, and pain. | Br J Pharmacol | 2026 | 41956525 | PubTator, text mining | PubMed |
| Biochemical and Immunohistochemical Associations of TDP-43 and Cryptic RNA With Hippocampal and Amygdala Volumetrics in Alzheimer's Disease. | Ann Neurol | 2026 | 41952326 | PubTator, text mining | PubMed |
| Calmodulin assists during co-translational folding of the KV7.2 channel calcium responsive domain. | Protein Sci | 2026 | 41949262 | PubTator, text mining | PubMed |
| A hypothesis on restoring neuronal membrane potential in dementia: early hit identification of 4-IPBA as a potential ion-channel modulator. | In Silico Pharmacol | 2026 | 41930241 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3785/papers?page=2